Navigation Links
Cord Blood America CEO Matthew Schissler Expands on Thought Process in Owning Stem Cell Laboratory
Date:5/15/2009

SANTA MONICA, Calif., May 15 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that Company founder and CEO Matthew Schissler, in a FirstCall In audio interview with analyst Francis Gaskins, explains the thought process behind the Company owning its own stem cell laboratory.

The interview and associated web links are available at http://www.investorcalendar.com/IC/ClientPage.asp?ID=145109.

An analyst report compiled by Mr. Gaskins, which details Cord Blood America's effort to become cash flow positive this year, is available at http://gaskinsco.com/linkto-cbai.shtml

"The laboratory will allow Cord Blood America to store the cells of its clients, potentially saving a tremendous amount of money in the long run," Mr. Schissler said. "Also, it allows CBAI to sell storage services to other cryogenic tissue storage companies, and allows Cord Blood America to diversify its stem cell storage base, opening up the market greatly. This vertical integration will create a competitive advantage for the Company."

For further updated information, please follow Cord Blood America at http://twitter.com/StemCellBanking, http://twitter.com/cbai, and http://stem-cell-banking.blogspot.com/ .

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

        CONTACT:
        Paul Knopick
        E & E Communications
        949/707-5365
        pknopick@eandecommunications.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
2. Viral Infection Might Trigger High Blood Pressure
3. Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory
4. New research confirms milestone study on blood pressure meds
5. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
6. Study finds iron levels not predictive of survival for form of blood cancer
7. Genes Yield Clues to High Blood Pressure
8. Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study
9. Too-Low Blood Pressure Can Also Bring Danger
10. All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke
11. Phone Monitoring May Help Lower Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... ... needed and will ultimately do significant harm to people with all chronic conditions, ... , "While it leaves in place the Affordable Care Act (ACA) requirement that ...
(Date:6/23/2017)... Newburgh, NY (PRWEB) , ... June 23, 2017 ... ... board certified plastic surgeon practicing in Newburgh, New York, has recently begun offering ... look. Committed to offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ensuring meat products ... videos highlight the importance of correctly using a meat thermometer. The videos feature ... extensive research on consumer food safety habits. Dr. Bruhn explains the variety of ...
(Date:6/23/2017)... ... 23, 2017 , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) ... Management Agency’s (FEMA) recent update of flood zones, more people than ever are ... was enacted to reflect the actual risk in flood zone areas during a ...
(Date:6/23/2017)... ... ... All-Star Insurance, a family managed agency that offers insurance management assistance and personal ... of a new charity drive to benefit women in the area diagnosed with breast ... estimated 252, 710 new cases of invasive or high risk breast cancer will be ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
(Date:6/8/2017)... , June 8, 2017  StatLab ... leading developer and manufacturer of diagnostic supplies ... today that Cressey & Company LP ("Cressey ... has completed a growth-focused investment in the ... majority ownership position from selling shareholder, Prairie ...
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
Breaking Medicine Technology: